Circulation · 2002 · 40 citations · 32 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical CardiologyPreventive CardiologyCardiac BiomarkersCardiovascular DiseaseHeart FailureHeart Failure PharmacotherapyCardiac Systolic FunctionCardiomyocyte EnergeticsCompetitive Polymerase Chain ReactionHeart Failure PharmacologyHeart Failure PhysiologyLeft Ventricular PhysiologyMyocardial InotropyReverse Transcription Polymerase Chain Reaction (Rt-pcr)
BACKGROUND: The purpose of this study was to compare long-term effects of cariporide with those of losartan in postinfarction heart failure. METHODS AND RESULTS: Female Sprague-Dawley rats with large myocardial infarctions and sham controls were randomized to losartan, cariporide, or placebo after 7 days and treated for 49 days. Cardiac function was assessed by echocardiography and measurement of left ventricular pressures, and gene expression was assessed by competitive reverse transcription-polymerase chain reaction. Cell dimensions, shortening, and relaxation were determined by videomicroscopy and calcium transients by fura 2. Losartan reduced postinfarction systolic and diastolic left ventricular dilation (by 24% and 31%, respectively), left and right ventricular weight (by 22% and 26%, respectively), and cardiomyocyte hypertrophy length and width (by 62% and 54%, respectively). Induction of myocardial atrial natriuretic peptide decreased 66%. Cariporide did not affect postinfarction hypertrophy or atrial natriuretic peptide. Losartan and cariporide respectively improved reduced cellular contractility (55% and 30%) and reduced elevated systolic (86% and 27%) and diastolic (49% and 43%) calcium. Losartan and cariporide respectively reduced prolonged time to 50% relaxation (66% and 25%) and time to 50% calcium reduction (55% and 53%). CONCLUSIONS: Losartan and cariporide improve cardiomyocyte contractility and calcium regulation in chronic heart failure. Losartan has salutary effects on postinfarction remodeling and gene expression, whereas cariporide is neutral.
32
Bertram Pitt, Philip A. Poole‐Wilson, Robert Segal et al. · The Lancet · 2000 · 2K citations
Junichi Sadoshima, Yuhui Xu, Henry S. Slayter et al. · Cell · 1993 · 1.4K citations